Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Abbott Dartford Murex Biotech Ltd"

22:10 EDT 20th April 2014 | BioPortfolio

Original Source: Murex Biotech Limited

Murex Biotech Ltd is part of the diagnostics division and is one of four Abbott sites within the UK. The company has steadily expanded to comprise a total UK workforce of over 2500 employees. At Murex, we are dedicated to the development and manufacture of products for the: detection monitoring screening of infectious diseases and other medical conditions. Murex is based at Dartford, Kent, and its principle focus is a range of enzyme immunoassay products for use by blood transfusion services throughout...

Matching Channels

Abbott

The 11th largest pharmaceutical company in the world, Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the medical device arm of the company, products of...

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

Matching News

Abbott Hosts Conference Call for First-Quarter Earnings

ABBOTT PARK, Ill., April 1, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2014 financial results on Wednesday, April 16, 2014, before the market opens.  The announceme...

Exclusion of gay juror forces new U.S. trial between GSK, Abbott

SAN FRANCISCO (Reuters) - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeal...

Abbott Declares 361st Consecutive Quarterly Dividend

ABBOTT PARK, Ill., Feb. 21, 2014 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 22 cents per share. (Photo: http://photos.prnewswire....

UPDATE 1-Exclusion of gay juror forces new U.S. trial between GSK, Abbott

SAN FRANCISCO, Jan 21 (Reuters) - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federa...

Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2013 Earnings

ABBOTT PARK, Ill., Jan. 6, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter and full-year 2013 financial results on Wednesday, Jan. 22, 2014, before the market opens.  T...

GSK gets new trial against Abbott over gay juror issue: U.S. court

SAN FRANCISCO (Reuters) - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeal...

GSK gets new trial against Abbott over gay juror issue -U.S. court

SAN FRANCISCO, Jan 21 (Reuters) - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federa...

Abbott to Present at J.P. Morgan Healthcare Conference

ABBOTT PARK, Ill., Dec. 19, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the 32nd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2014. Thomas C. Freyman, executive...

Matching PubMed Articles

Biotech methods and advances.

Cover illustration: Our latest Biotech Methods & Advances special issue is edited by our Editors-in-Chief Prof. Alois Jungbauer and Prof. Sang Yup Lee. As always, the special issue is a collection of...

Editorial: Latest methods and advances in biotechnology.

The latest "Biotech Methods and Advances" special issue of Biotechnology Journal continues the BTJ tradition of featuring the latest breakthroughs in biotechnology. The special issue is edited by our...

What's fueling the biotech engine-2012 to 2013.

Biotech patents and science policy: the Spanish experience.

Sequence Conservation of the Region Targeted by the Abbott RealTime HCV Viral Load Assay.

The Abbott RealTime (RT) HCV assay targets the 5'-UTR of the HCV genome. Here we analyzed the sequence variability of the assay target region from 1092 specimens. Thermodynamic modeling of the percent...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement